rethinkPeptides Search
Menu
Study breakdown

Low Oxygen Triggers Blood-Brain Barrier Cells to Produce More Adrenomedullin

In VitroPreliminary evidence
The takeaway

Hypoxia upregulated both adrenomedullin production and its receptor in brain astrocytes and endothelial cells, suggesting a coordinated protective response at the blood-brain barrier during ischemia.

Coordinated upregulation

Both the vasodilatory peptide ADM and its receptor increased together during hypoxia — ensuring the protective signal is both made and received

What the researchers found

Hypoxia induced coordinated upregulation of adrenomedullin and its receptor RDC-1 in brain astrocytes and endothelial cells, with NF-κB-mediated transcriptional activation, suggesting an autocrine/paracrine protective mechanism at the blood-brain barrier.

Why it matters

Stroke and brain ischemia cause devastating damage. Understanding the brain's built-in protective responses, including ADM upregulation, could lead to therapies that enhance these natural defenses during stroke.

How the study worked

In-vitro study using cultured rat brain astrocytes and endothelial cells. Hypoxia exposure with measurement of ADM mRNA, protein, and RDC-1 receptor expression. Gene reporter assays identified NF-κB involvement.

What this study cannot tell us

In-vitro study in isolated cells. The in-vivo relevance of this coordinated upregulation during actual stroke or ischemia needs confirmation.

How to read the evidence

Preliminary in-vitro evidence with clear mechanistic data including transcription factor identification, but lacking in-vivo confirmation.

When this study was published

Published in 2000. Adrenomedullin's neuroprotective role during ischemia has been further characterized, supporting its potential in stroke therapy.

The bigger picture

The brain has evolved sophisticated self-protective mechanisms for oxygen deprivation. ADM's coordinated upregulation with its receptor ensures the protective signal is both produced and received at the blood-brain barrier.

Questions still open

  • Could ADM administration protect the brain during stroke?
  • Does the coordinated receptor upregulation explain why ADM is effective at the blood-brain barrier?
  • Can the NF-κB pathway be targeted to enhance ADM-mediated brain protection?

Common questions

How does the brain protect itself during low oxygen?
Brain cells detect low oxygen and increase production of adrenomedullin, a vasodilator. This relaxes brain blood vessels to restore blood flow. The cells also increase the receptor for this peptide, ensuring the signal is received.
Could this help stroke patients?
If we can enhance this natural protective response — either by administering adrenomedullin or by boosting its production — it might protect brain tissue during stroke and reduce brain damage.

Read the original research

Coordinated Up-regulation by hypoxia of adrenomedullin and one of its putative receptors (RDC-1) in cells of the rat blood-brain barrier.

The Journal of biological chemistry, 275(51), 39914-9

Citation

Ladoux, A; Frelin, C. (2000). Coordinated Up-regulation by hypoxia of adrenomedullin and one of its putative receptors (RDC-1) in cells of the rat blood-brain barrier.. The Journal of biological chemistry, 275(51), 39914-9.